US12410232B2

Treatment of a canine CD20 positive disease or condition using a canine CD20- …

University of Texas System

Abstract

The present invention relates to compositions and methods for the treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor. One aspect includes a modified canine T cells and pharmaceutical compositions comprising the modified cells for …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Nicola Mason
Priority date: July 10, 2015
Filing date: August 31, 2021
Grant date: September 09, 2025
Publication date: September 09, 2025
Language: en
PDF source: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12410232
Metadata fetched: August 29, 2026 00:33